Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

swag

(26,486 posts)
Thu Apr 16, 2020, 05:38 PM Apr 2020

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

Source: STAT

By ADAM FEUERSTEIN @adamfeuerstein and MATTHEW HERPER @matthewherper

A Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.

Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests. The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies. If safe and effective, it could become the first approved treatment against the disease.

The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir.

Related: ‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film
“The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.

Her comments were made this week during a video discussion about the trial results with other University of Chicago faculty members. The discussion was recorded and STAT obtained a copy of the video.

Read more: https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus-drug-suggests-patients-are-responding-to-treatment/

35 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment (Original Post) swag Apr 2020 OP
Excellent, fantastic, wonderful pbmus Apr 2020 #1
Good news. nt SunSeeker Apr 2020 #2
Great news. Nearly all of the 125 people responded well to the drug and been discharged. iluvtennis Apr 2020 #3
There is also a placenta-based cell-therapy product showing early promise R Merm Apr 2020 #4
Error 404 - Page not found Sorry but the page you are looking for cannot be found riversedge Apr 2020 #8
Try this link R Merm Apr 2020 #11
Fantastic news! DeminPennswoods Apr 2020 #5
Thank you for posting this. n/t Ellipsis Apr 2020 #6
good news. we needed some for this horrible disease. riversedge Apr 2020 #7
That is good news. cayugafalls Apr 2020 #9
Is Trump invested in this company? keithbvadu2 Apr 2020 #10
Surprise! PennyK Apr 2020 #13
When I hear the name Gilead Karma13612 Apr 2020 #19
Same. Tucker08087 Apr 2020 #20
LOL! Karma13612 Apr 2020 #30
Mine said the same about Walking Dead. Tucker08087 Apr 2020 #33
Well, if you do ever get a chance, Karma13612 Apr 2020 #34
It will hype the market until they find out its not the wonder drug they thought it was. Its all yaesu Apr 2020 #22
Hear! Hear! for any little COVID-19 ray of medical sunshine! MFGsunny Apr 2020 #12
Wait a minute- without MORE SD, Gilead probably wouldn't be able to keep up with demand nitpicker Apr 2020 #14
Over the last two weeks nitpicker Apr 2020 #17
It's unlikely there will be enough for everyone DrToast Apr 2020 #28
Best news of my day! Thank you for posting!! onetexan Apr 2020 #15
So wonderful to see some good news! IronLionZion Apr 2020 #16
Trump loses again The Nurse Apr 2020 #18
Trump has a Gilead Lobbyist in his cabinet! MartyTheGreek Apr 2020 #21
yep, I take all of this magic bullet stuff with a grain of salt. nt yaesu Apr 2020 #24
Cue Paul Robeson.... Tanuki Apr 2020 #23
👏👏👏 SheltieLover Apr 2020 #25
I'm sure their stock loves this YUGE news, sounds like more stock market hype pretending to be yaesu Apr 2020 #26
It's good news, but not a silver bullet DrToast Apr 2020 #27
Data allegedly leaked from a small clinical trial does not indicate a treatment. NNadir Apr 2020 #29
This is encouraging, but BillyBobBrilliant Apr 2020 #31
I believe that the sample is not representative but skewed toward a subset bluedye33139 Apr 2020 #32
Crossing fingers denbot Apr 2020 #35

iluvtennis

(19,843 posts)
3. Great news. Nearly all of the 125 people responded well to the drug and been discharged.
Thu Apr 16, 2020, 05:47 PM
Apr 2020

Fingers crossed.

riversedge

(70,174 posts)
8. Error 404 - Page not found Sorry but the page you are looking for cannot be found
Thu Apr 16, 2020, 06:00 PM
Apr 2020

Is you like correct. Looks like an interesting article.

cayugafalls

(5,639 posts)
9. That is good news.
Thu Apr 16, 2020, 06:03 PM
Apr 2020

They were doing a second clinical trial in China, but recently China halted that trial.

There are also some compassionate use trials going on that look promising as well.

Karma13612

(4,547 posts)
30. LOL!
Fri Apr 17, 2020, 09:14 AM
Apr 2020

Yea, I try to remind myself that it’s just a “ko-inky-dink”, but it always gets me for moment or two.

Hubby said he doesn’t want to watch anymore episodes of the show during the pandemic. Says it seems too prophetic.

Tucker08087

(621 posts)
33. Mine said the same about Walking Dead.
Sat Apr 18, 2020, 06:44 PM
Apr 2020

I said not to worry. MAGA cult members never had any brains to begin with, so I think we’re good.

I don’t get that TV channel but I read the books. The show has gone much further than the novel. I read episode recaps because I’m curious. I hope they release DVDs one day.

yaesu

(8,020 posts)
22. It will hype the market until they find out its not the wonder drug they thought it was. Its all
Thu Apr 16, 2020, 06:58 PM
Apr 2020

about saving the banksters, not saving lives.

MFGsunny

(2,356 posts)
12. Hear! Hear! for any little COVID-19 ray of medical sunshine!
Thu Apr 16, 2020, 06:11 PM
Apr 2020

Gratis Laugh track ::
will KellyAnn Dumbway want to know those other 18 rays also??

nitpicker

(7,153 posts)
14. Wait a minute- without MORE SD, Gilead probably wouldn't be able to keep up with demand
Thu Apr 16, 2020, 06:13 PM
Apr 2020

My personal translation of this Gilead puff piece, apparently from late March:

https://www.gilead.com/purpose/advancing-global-health/covid-19/working-to-supply-remdesivir-for-covid-19

"IF everything works out all right, we might be able to keep up with projected demand by the seriously ill.""

((BUT what if there are production/distribution snags? Or caseload resurges?))

nitpicker

(7,153 posts)
17. Over the last two weeks
Thu Apr 16, 2020, 06:23 PM
Apr 2020

Worldwide REPORTED new cases were about 1.2 million with about 100K deaths.

That's about 2.5 million cases and 200K deaths a month.

The puff piece projected output averaging 70K courses a month from May to October 2000.

So, if this IS a magic bullet-who will get the treatment and who will not, if no extra SD efforts are made?

yaesu

(8,020 posts)
26. I'm sure their stock loves this YUGE news, sounds like more stock market hype pretending to be
Thu Apr 16, 2020, 07:07 PM
Apr 2020

mainstream news.

DrToast

(6,414 posts)
27. It's good news, but not a silver bullet
Thu Apr 16, 2020, 07:21 PM
Apr 2020

Remdesiver has to be administered via IV. It is also difficult and time consuming to manufacture. Demand will be high and supply limited.

NNadir

(33,509 posts)
29. Data allegedly leaked from a small clinical trial does not indicate a treatment.
Thu Apr 16, 2020, 08:07 PM
Apr 2020

In normal times, this would be a small phase II clinical trial, and, I note, no statistics are supplied.

BillyBobBrilliant

(805 posts)
31. This is encouraging, but
Fri Apr 17, 2020, 11:48 AM
Apr 2020

At this point it is not a scientific study based on double blind protocols.
There is such a study underway to determine the effectiveness of Remdesivir, here at the UT Health Science Center, San Antonio by the Infectious disease department. So, literally the jury is still out. Hoping however...

bluedye33139

(1,474 posts)
32. I believe that the sample is not representative but skewed toward a subset
Fri Apr 17, 2020, 01:18 PM
Apr 2020

In a crisis situation, asking patients to do a study is already a form of selection. People who agree to do a study will produce results about the effects of a drug in the population that voluntarily accepts an experimental drug during an infection that could be lethal.

People who would say yes to that question are a subset of the larger population. The question probably would screen out anyone with autoimmune problems, immune impairment, life-threatening pre-existing conditions, etc.

And people with these pre-existing conditions are the vulnerable population that any drug would need to protect.

It is unlikely that the population which agrees to take an experimental drug is representative of the population as a whole.

Nonetheless, I am cautiously optimistic. If the drug can inhibit viral reproduction even to a slight extent, that could tip the scale for many people. A person's immune system would be able to handle the infection throughout the body much easier if the virus were crippled. The antiviral drugs may be the way out

denbot

(9,899 posts)
35. Crossing fingers
Mon Apr 20, 2020, 03:25 AM
Apr 2020

Thank you for lighting a candle in the darkness swag. Also, it’s good to see you posting. It doesn’t seem like you do this very often anymore.

Latest Discussions»Latest Breaking News»Early peek at data on Gil...